Literature DB >> 14765009

Impact of the Powys Macmillan GP clinical facilitator project: views of health-care professionals.

Bill Noble1, Philippa Hughes, Christine Ingleton, Jane Berg, David Clark.   

Abstract

The UK charity, Macmillan Cancer Relief, commissioned a 3-year pilot project employing 12 GP clinical facilitators (GPCFs). The aim was to raise the standard of generalist palliative care, provide extended clinical palliative care and provide a coordinated framework for commissioning specialist palliative and cancer care in Powys, rural Wales. As part of the comprehensive evaluation, surveys of GPCFs, GPs, district nurses and community hospital nurses were undertaken in order to record changes in palliative care activity, specialist palliative care services and training needs. Services providing 24-hour nursing and social services were perceived as in need of development. Referrals to Macmillan nurses increased by 40% and GPs reported that time spent on palliative care increased, on average, from a quarter of a day to half a day per week, although district nurses reported a reduction in palliative care activity. The majority of nurses thought that the GPCF's contribution was important. The use of local palliative care guidelines increased significantly among district nurses by the end of the project.

Entities:  

Mesh:

Year:  2003        PMID: 14765009     DOI: 10.12968/ijpn.2003.9.12.11988

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  2 in total

1.  Evaluation of a scheme to enhance palliative cancer care in rural Wales.

Authors:  David Clark; Christine Ingleton; Philippa Hughes; Tom Yap; Bill Noble
Journal:  Support Care Cancer       Date:  2004-10       Impact factor: 3.603

2.  Conceptual foundations of a palliative approach: a knowledge synthesis.

Authors:  Richard Sawatzky; Pat Porterfield; Joyce Lee; Duncan Dixon; Kathleen Lounsbury; Barbara Pesut; Della Roberts; Carolyn Tayler; James Voth; Kelli Stajduhar
Journal:  BMC Palliat Care       Date:  2016-01-15       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.